- melanoma. Anti-CD22
immunotoxins,
being tested in
hairy cell
leukemia Antibody-drug conjugates, most, if not all, are
immunotoxins but use
whole antibodies...
- S2CID 32655907.
cited in:
Wayne AS,
Fitzgerald DJ,
Kreitman RJ,
Pastan I (2014). "
Immunotoxins for leukemia". Blood. 123 (16): 2470–7. doi:10.1182/blood-2014-01-492256...
-
acting as
immunotoxin. As of
August 2009,
several anti-CD22
immunotoxins are
undergoing clinical trials. CAT-3888 or BL22 is an anti-CD22
immunotoxin and in...
-
sufficiently lessen the
likelihood that the
ricin component of
these immunotoxins will
cause the
wrong cells to
internalize it,
while still retaining its...
- Anti-CD19
immunotoxin is a
monoclonal antibody linked to a
toxic substance. It is
being studied in the
treatment of some
types of B-cell cancer. Anti-CD19...
-
Other potential risk
factors include mechanical trauma and
exposure to
immunotoxins.
There is no
strong evidence for a
genetic link or a link to
family history...
-
diftitox uses
diphtheria toxin as an
antineoplastic agent.
Resimmune is an
immunotoxin that is in
clinical trials in
cutaneous T cell
lymphoma patients. It...
-
diphtheria toxin have also been used,
again with
variations in success.
Immunotoxins consisting of a
monoclonal antibody linked to
saporin have been developed...
- the USAN Council:
Vedotin Dosio, F.; Brusa, P.; Cattel, L. (2011). "
Immunotoxins and
Anticancer Drug
Conjugate ****emblies: The Role of the
Linkage between...
-
Trinitrotoluene (/ˌtraɪˌnaɪtroʊˈtɒljuiːn/), more
commonly known as TNT (and more
specifically 2,4,6-trinitrotoluene, and by its
preferred IUPAC name 2-methyl-1...
